Results 121 to 130 of about 17,574 (294)

Experimental Evaluation of Interchangeability in Soft CSPs.

open access: yes, 2003
In [8], Freuder defined interchangeability for classical Constraint Satisfaction Problems (CSPs). Recently [2], we extended the definition of interchangeability to Soft CSPs and we introduced two notions of relaxation based on degradation ?
Bistarelli, Stefano
core  

Purification and preparation of Marchantia polymorpha Auxin Response Factor 2 for phase separation studies

open access: yesFEBS Open Bio, EarlyView.
We describe detailed protocols for the purification and preparation of Marchantia polymorpha Auxin Response Factor 2 (MpARF2). This protein is fused to an MBP solubility tag and an mNG fluorescent tag and is purified from Escherichia coli. The presented procedures make it possible to study MpARF2 assemblies, which could arise from phase separation ...
Bas Janssen   +5 more
wiley   +1 more source

Control of adverse drug reactions in HIV/AIDS antiretroviral treatment with interchangeable medicines

open access: yesБезопасность и риск фармакотерапии, 2018
Review on assessment data of ADR, which must be monitored during antiretroviral therapy in patients with HIV/AIDS are presented. Questions of drug safety acquire particular importance in conducting pharmacotherapy of the most socially significant ...
M. V. Zhuravleva   +5 more
doaj  

Safety of Switching from a Reference Biologic to Its Biosimilar: A Systematic Review and Meta-Analysis

open access: yesBiologics
Background: Biosimilars are designed to closely resemble their reference biologics in terms of quality, safety, and efficacy, with only minor variations in clinically inactive components and manufacturing methods.
Sarah Saad Aljahili   +6 more
doaj   +1 more source

Interchangeability on Formulary Coverage of Adalimumab Biosimilars in Medicare Part D

open access: yes
Interchangeability on Formulary Coverage of Adalimumab Biosimilars in Medicare Part
Feng, Alina
core   +1 more source

Strict Equilibria Interchangeability in Multi-Player Zero-Sum Games

open access: yes, 2020
The interchangeability property of Nash equilibria in two-player zerosum games is well-known. This paper studies possible generalizations of this property to multi-party zero-sum games.
Pavel Naumov, Italo Simonelli
core  

Protocol for quantifying miRNA trafficking across the endosomal membrane

open access: yesFEBS Open Bio, EarlyView.
An in vitro protocol measures miRNA uptake into endosomes isolated from mammalian cell extracts, which are free of subcellular contaminants. Performed at 37 °C in the presence of ATP, it ensures the import of single‐stranded miRNA into the endosomal lumen.
Syamantak Ghosh   +2 more
wiley   +1 more source

Interchangeability and maintainability of electric vehicles in the context of industry development

open access: yesAvtomobilʹnyj Transport (Harʹkov)
Problem. The rapid growth of the global electric vehicle (EV) market is accompanied by a low level of interchangeability and maintainability of key components, leading to increased maintenance costs, dependence on authorized service centers, and ...
Gorbenko Oleksandr, Lazorenko Andrii
doaj   +1 more source

Heterotropic regulation and negative homotropic cooperativity

open access: yesFEBS Open Bio, EarlyView.
We identified a structural module common to some proteins that couple negative cooperativity with heterotropic regulation, two features that rarely coexist. These proteins are ring‐like and present an ordered asymmetry whereby noncontacting subunits are symmetric, and their tertiary structure differs from that of contacting subunits.
Veronica Morea   +5 more
wiley   +1 more source

From patient advocacy to patient‐driven research: Building active partnerships beginning at the bench to reach the bedside

open access: yesFEBS Open Bio, EarlyView.
Research is strongest when conducted alongside patients, not just about them. Patient research organizations help integrate patient perspectives into research priorities, study design, and scientific meetings, leading to meaningful patient outcomes and development of relevant therapies.
Jenica H. Kakadia   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy